120 results
Page 5 of 6
6-K
86zslgdbnow m5z9
15 Jan 20
Current report (foreign)
8:35pm
6-K
EX-99.1
mes0zm
10 Dec 19
ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix
12:00am
6-K
EX-99.2
qsq 1h2e6jx
7 Nov 19
Current report (foreign)
9:11am
6-K
EX-99.3
klkh 8ihro982vihp7
7 Nov 19
Current report (foreign)
9:11am
6-K
EX-99.1
24wwt4js1evv r54tdy
31 Oct 19
ObsEva Announces Clearance to Initiate Pivotal US Phase 3 Clinical
4:21pm
6-K
EX-99.1
mq42y76pfkdobudls
12 Sep 19
ObsEva announces new composition of its Executive Committee
8:16am
6-K
EX-99.1
q8xpx8txj9d
6 Sep 19
ObsEva Reports New Clinical Evidence of Nolasiban Mechanism of
8:27am
F-3
EX-4.2
evnshn54550
7 Aug 19
Shelf registration (foreign)
8:24am
6-K
EX-99.1
4ddbepk8llf1lk1m80md
7 Aug 19
Current report (foreign)
7:21am
6-K
EX-99.3
4ejb2 v3w9fp
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
mzw1u573zw1c 0jec7mj
5 Jul 19
Current report (foreign)
6:01pm
6-K
chnfk0 pc
19 Jun 19
Current report (foreign)
4:30pm
6-K
EX-99.3
3jysvra88 o3v88fh
9 May 19
Index to Unaudited Condensed Consolidated Financial Statements
6:05am
6-K
EX-99.3
8q0d5fvyew7sbsqod
8 Nov 18
Index to Unaudited Condensed Consolidated Financial Statements
9:28am
6-K
xp152h
9 Oct 18
Current report (foreign)
4:42pm
6-K
iq6a9mcle
3 Oct 18
Current report (foreign)
9:07am
6-K
qz98ub
28 Sep 18
Current report (foreign)
8:40am